Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02232243
Title HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Peng Wang
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Kentucky, Markey Cancer Center Lexington Kentucky 40536 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field